These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2287053

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
    Sasai Y, Iwai T, Tamura A, Nakazawa N, Ueda Y, Kaneko H, Horiike S, Yokota S, Taniwaki M, Kashima K, Misawa S, Tsuda S, Ohgawara Y.
    Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
    Nagao T, Komatsuda M, Yamauchi K, Nozaki H, Arimori S.
    Tokai J Exp Clin Med; 1981 Oct; 6(4):415-20. PubMed ID: 6459664
    [Abstract] [Full Text] [Related]

  • 6. [Therapeutic effects of micronomicin against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
    Hasegawa H, Horiuchi A, Nagai K, Kanamaru A, Masaoka T, Shibata H, Kitani T, Taniguchi N, Yasunaga K, Okamoto Y.
    Jpn J Antibiot; 1985 Aug; 38(8):2129-38. PubMed ID: 3908733
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of a combination treatment with cefminox and fosfomycin for infections complicated in patients with hematological disorders].
    Seriu T, Tsuda S, Nakai H, Murakami T, Takashima T, Takahashi Y, Tanaka S, Nakagawa H, Nishigaki H, Yokota S.
    Jpn J Antibiot; 1991 Nov; 44(11):1197-205. PubMed ID: 1784070
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
    Yamane T, Tanaka K, Hasuike T, Hirai M, Misu K, Ota K, Ohira H, Nakao Y, Yasui Y, Inoue T.
    Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical experience of chemotherapy with cefmetazole for severe infections accompanying malignant hematological disorders].
    Fujii S, Fujii Y, Inoue Y, Okubo M, Matsutani A, Kaku K, Yaga K, Kaneko T.
    Jpn J Antibiot; 1989 Mar; 42(3):573-8. PubMed ID: 2664248
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical investigation of the therapeutic effects of cefmenoxime in the treatment of infections complicated by hematological diseases].
    Kozuru M, Kurata T, Uike N, Niho Y, Shibuya T, Otsuka T, Yamano Y, Hirota Y, Nishimura J, Katsuno M.
    Jpn J Antibiot; 1986 Mar; 39(3):701-12. PubMed ID: 3488422
    [Abstract] [Full Text] [Related]

  • 17. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T, Tsuda S, Misawa S, Horiike S, Kuzuyama Y, Hirakawa K, Nakai H, Seriu T, Tanaka S, Nishida K.
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.